A San Diego molecular diagnostic company announced Tuesday that it has received fast-track emergency approval from the Food and Drug Administration for its COVID-19 diagnostic test, which the company ...

The in vitro diagnostics industry has turned in an impressive response to the COVID-19 pandemic, but a few problems are bound to surface. The U.S. FDA reported May 10 that the Accula test by San Diego ...

If you want to know immediately whether you are negative for COVID-19 and therefore can travel, 11 U.S. airports will be able to tell you. But it will cost you. In a story published by Travel Weekly, ...

Mesa Biotech has recalled some of its COVID-19 tests because they may give false positive results after it was determined the facility where they were made was contaminated. The recalled Accula ...

SAN DIEGO, Nov. 13, 2018 /PRNewswire/ -- Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) testing ...

SAN DIEGO, Nov. 27, 2018 /PRNewswire/ -- Mesa Biotech Inc., is a privately held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) ...

The US just gave companies almost $250 million to speed up coronavirus testing. The National Institutes of Health selected the seven companies out of 650 applicants. Some tests deliver results minutes ...

Mesa Biotech, a privately held San Diego startup that designs point-of-care flu tests, has received emergency authorization from federal authorities to provide a molecular test for the COVID-19 ...

Mesa Biotech, a privately held San Diego company that developed one of the first rapid COVID-19 diagnostic tests to get regulatory approval, has been acquired by life sciences giant Thermo Fisher ...

In the United States, the average wait time for COVID-19 test results is about four days. Even worse, 10 percent of individuals don’t receive lab results for 10 days or more. Quick reporting of test ...

NORFOLK, Va. — With states reopening and people returning to work, employers are faced with a new challenge: testing for COVID-19. “If a job site shoots up high on the positive list -- like 20, 30, or ...